Bortezomib is an anticancer formulation that comprises Atezolizumab, a monoclonal antibody agent. It is used in the treatment of individuals suffering from urothelial carcinoma, small cell lung cancer (SCLC), hepatocellular carcinoma, non-small cell lung cancer (NSCLC), and triple-negative breast cancer (TNBC). This regimen is given as an injection intravenously. Enquire about bortezomib injection on Magicine Pharma and get exclusive deals.

Bortezomib is an anticancer formulation that comprises Atezolizumab, a monoclonal antibody agent. It is used in the treatment of individuals suffering from urothelial carcinoma, small cell lung cancer (SCLC), hepatocellular carcinoma, non-small cell lung cancer (NSCLC), and triple-negative breast cancer (TNBC). This regimen is given as an injection intravenously. Enquire about bortezomib injection on Magicine Pharma and get exclusive deals.